|
|
This decision follows the FDA's issuance of an Approvable Letter for ProDisc-C in October 2007 (see Media Release dated October 25, 2007). The clinical review had been completed at that time.
The remaining review of the associated manufacturing processes has now also been concluded and the FDA has determined that the respective requirements of the Quality System Regulations are fulfilled.
|